NP

Niranjan B. Pandey

The Johns Hopkins University: 8 patents #182 of 4,416Top 5%
Johnson & Johnson: 4 patents #2,223 of 7,810Top 30%
AT Alba Therapeutics: 2 patents #10 of 17Top 60%
📍 White Marsh, MD: #3 of 22 inventorsTop 15%
🗺 Maryland: #2,000 of 35,612 inventorsTop 6%
Overall (All Time): #338,604 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Showing 1–14 of 14 patents

Patent #TitleCo-InventorsDate
11981754 Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases Aleksander S. Popel, Esak Lee, Jordan J. Green, Ron B. Shmueli 2024-05-14
11674959 Methods for identifying and preparing pharmaceutical agents for activating Tie1 and/or Tie2 receptors Aleksander S. Popel, Jordan J. Green, Adam Mirando 2023-06-13
11155603 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis- dependent diseases Aleksander S. Popel, Elena V. Rosca, Jacob E. Koskimaki, Corban G. Rivera, Amir Tamiz 2021-10-26
10774112 Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases Aleksander S. Popel, Esak Lee, Jordan J. Green, Ron B. Shmueli 2020-09-15
10774131 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases Aleksander S. Popel, Elena V. Rosca, Jacob E. Koskimaki, Corban G. Rivera, Amir Tamiz 2020-09-15
10106597 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphangiogenesis-dependent diseases Aleksander S. Popel, Elena V. Rosca, Jacob E. Koskimaki, Corban G. Rivera, Amir Tamiz 2018-10-23
9802984 Biomimetic peptide and biodegradable delivery platform for the treatment of angiogenesis- and lymphangiogenesis-dependent diseases Aleksander S. Popel, Esak Lee, Jordan J. Green, Ron B. Shmueli 2017-10-31
9056923 Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases Aleksander S. Popel, Elena V. Rosca, Jacob E. Koskimaki, Corban G. Rivera, Amir Tamiz 2015-06-16
8796203 Use of tight junction antagonists to treat inflammatory bowel disease Blake Paterson, Amir Tamiz 2014-08-05
8299017 Use of tight junction antagonists to treat inflammatory bowl disease Blake Paterson, Amir Tamiz 2012-10-30
7659284 Thiazolopyridine kinase inhibitors Peter J. Connolly, Sigmond Johnson, Steven A. Middleton 2010-02-09
7605154 Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors Eva Binnun, Peter J. Connolly, Sigmond Johnson, Ronghui Lin, Steven A. Middleton +2 more 2009-10-20
7579356 Thia-tetraazaacenaphthylene kinase inhibitors Kathleen Battista, Gilles Bignan, Peter J. Connolly, Stuart Hayden, Sigmond Johnson +2 more 2009-08-25
7427625 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors Peter J. Connolly, Stuart Emanuel, Stuart Hayden, Sigmond Johnson, Bharat Lagu +2 more 2008-09-23